AstraZeneca gets FDA ok for lymphocytic leukemia drug

AstraZeneca announced that the U.S. FDA has approved Calquence for adult patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news